
CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
Healthcare spending is expected to dip in 2013, but projections indicate that the spending could jump significantly in 2014 because of PPACA.






